About
Serge Saxonov co-founded 10x Genomics and has served as its Chief Executive Officer and a director since July 2012. He also served as the company's President from July 2012 until October 2012.
Before co-founding 10x Genomics, he was Vice President of Applications at QuantaLife, a privately held life sciences company that developed a droplet digital PCR platform, and earlier was Founding Architect and Director of research and development at 23andMe.
He received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.
Roles
10x Genomics, Inc.
Chief Executive Officer and Director · Current role
2012–present
10x Genomics
President · Served as President in addition to CEO during the company's earliest months.
July 2012 - October 2012
QuantaLife
Vice President of Applications · Privately held life sciences company developing a droplet digital PCR platform.
May 2010 - April 2012
23andMe
Founding Architect and Director of Research and Development · Privately held personal genomics and biotechnology company.
June 2006 - May 2010
Fixed Compensation
FY 2025Salary
$674,250
ComponentAnnual base salary
Total compensation
$6,329,244
Performance Compensation
Data from FY 2025Cash incentive
Annual cash incentive
$634,725
FormNon-Equity Incentive Plan Compensation
Stock awards
Stock awards
$5,020,269
FormStock awards
Also at 10x Genomics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.